跳至主要内容
临床试验/JPRN-jRCTs031180036
JPRN-jRCTs031180036已完成未知

sefulness of FDG-PET/CT to predict the response after anti-PD-1/PD-L1 antibody in patients with advanced non-small cell lung cancer: a multi-institutional study - FDG PD-1/PD-L1 Study

Kaira Kyoichi0 个研究点目标入组 58 人开始时间: 2018年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
58

研究概览

简要总结

Metabolic assessment by MTV or TLG was superior to morphological changes on CT for predicting the therapeutic response and survival at 4 weeks after PD-1 blockade in patients with advanced NSCLC.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1)Pathologically confirmed advanced non-small cell lung cancer (NSCLC)
  • 2)Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
  • 3)Patient with evaluable lesion based on RECIST
  • 4)Written informed consent

排除标准

  • 1)Pregnant woman
  • 2)Patients with obvious interstitial pneumonia or pulmonary fibrosis in the chest X-ray.
  • 3)Patients with collagen vascular disease or autoimmune diseases
  • 4)Other cases attending physician it is determined unsuitable for registration of the study

研究者

发起方
Kaira Kyoichi

相似试验